Ceramic hip resurfacing: a Metal-Free future for joint replacement?

NCT ID NCT03326804

Ongoing Disease control Sponsor: Embody Orthopaedic Limited Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study is testing a new type of hip resurfacing device made entirely of ceramic, designed for people with hip osteoarthritis, necrosis, or dysplasia. The goal is to see if it is as safe and effective as existing metal-on-metal devices, but without releasing metal ions into the body. Researchers will follow 250 patients for 10 years after surgery, tracking implant survival, pain, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: H1 Hip Resurfacing Arthroplasty device (ceramic-on-ceramic, non-cemented)
What this could lead to: If successful, this could offer a longer-lasting, metal-free hip replacement option that avoids metal ion release in the blood.
What could go wrong: This is an observational study, not a randomized trial, and long-term results over 10 years are needed to confirm safety and effectiveness. There are risks of complications like implant loosening or fracture.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS OF THE FEMORAL HEAD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis avascular necrosis of femoral head, primary, 1 developmental dysplasia of the hip Hip Dislocation osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP DYSPLASIA HIP NECROSIS HIP OSTEOARTHRITIS

Contacts and locations

Locations

Charing Cross Hospital

London, W6 8RF, United Kingdom
Kind Edward VII's Hospital

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.